Concepedia

Manfred Koegl

MK

Statistics

Publications

45

Citations

6.7K

H-Index

35

Active since

1993

Affiliations

Boehringer Ingelheim (Austria)(Current)

Heidelberg University

German Cancer Research Center

University of Dundee

European Molecular Biology Laboratory

Manfred Koegl is an author at Boehringer Ingelheim (Austria) specializing in life sciences, molecular biology, and biochemistry.

ORCID

Publications per year

1993–2024

45

Publications

45

A Novel Ubiquitination Factor, E4, Is Involved in Multiubiquitin Chain Assembly

Manfred Koegl, Thorsten Hoppe, Stephan Schlenker et al. · Cell · 1999 · 1.1K citations · Full text

, , +7

BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design

William Farnaby, Manfred Koegl, Michael J. Roy et al. · Nature Chemical Biology · 2019 · 576 citations · Full text

, , +9

Drugging an undruggable pocket on KRAS

Dirk Kessler, Michael Gmachl, Andreas Mantoulidis et al. · Proceedings of the National Academy of Sciences · 2019 · 434 citations · Full text

, , +15

Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel–Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7

Vittoria Zoppi, Scott J. Hughes, Chiara Maniaci et al. · Journal of Medicinal Chemistry · 2018 · 333 citations · Full text

, , +14

Csk inhibition of c‐Src activity requires both the SH2 and SH3 domains of Src.

Giulio Superti‐Furga, Stefano Fumagalli, Manfred Koegl et al. · The EMBO Journal · 1993 · 274 citations · Full text

, , +15

1–5 of 45